Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy

Norbert Pfeiffer1, Maria-Luise Scherzer2, Hubert Maier3, Sonja Schoelzel4, Mark C Jasek5, Jeanette A Stewart6, William C Stewart6 On behalf of the DuoTravMED study group1Johannes Gutenberg-Universit&auml;t Mainz, Mainz, Germany; 2Regenstauf, Germany; 3Gerolzhofen, Germany; 4Institutes of Mol...

Full description

Bibliographic Details
Main Authors:	Norbert Pfeiffer, Maria-Luise Scherzer, Hubert Maier, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-05-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/safety-and-efficacy-of-changing-to-the-travoprosttimolol-maleate-fixed-a4379

Similar Items

Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
by: Kozobolis V, et al.
Published: (2018-11-01)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
by: Miguel A Teus, et al.
Published: (2009-11-01)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost&ndash;timolol, bimatoprost/bimatoprost&ndash;timolol, and travoprost/travoprost&ndash;timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
by: Antoine Lafuma, et al.
Published: (2011-03-01)

Comparison of the effects of antiglaucomatous fixed combinations and patients compliance: Dorzolamide-timolol maleate and latanoprost-timolol maleate
by: Kubilay Çetinkaya, et al.
Published: (2012-03-01)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
by: Schnober D, et al.
Published: (2015-05-01)

Transdermal iontophoretic delivery of timolol maleate
by: Mayur Patni, et al.
Published: (2012-12-01)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
by: Nakano T, et al.
Published: (2016-12-01)

Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy
by: Jordão MLS, et al.
Published: (2014-08-01)

Symptomatic Bradycardia and Syncope due to Ophthalmic Timolol Maleate
by: Muge Gulen, et al.
Published: (2014-08-01)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
by: Swati Jagdale, et al.
Published: (2016-01-01)

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
by: Jaime Pablo Kelly Rigollet, et al.
Published: (2011-02-01)

Comparison of the efficacy and safety of fixed combination travoprost/timolol and dorzolamide/timolol in patients with primary open-angle glaucoma and ocular hypertension
by: Babić Nikola, et al.
Published: (2013-01-01)

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from &szlig;-blockers and prostaglandin analogs
by: Inoue K, et al.
Published: (2012-02-01)

Studies on the effect of timolol maleate on human corneal endothelial cells
by: Ting-Jun Fan, et al.
Published: (2013-06-01)

Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas
by: Yasmeen Jabeen Bhat, et al.
Published: (2016-01-01)

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate
by: Kakoli Roy, et al.
Published: (2012-01-01)

Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study
by: Kumar Harsh, et al.
Published: (2002-01-01)

The Yijing Buyang Huanwu Decoction combined with timolol maleate in the treatment of POAG
by: Xiao-Rong Zhang, et al.
Published: (2021-02-01)

Oftalmik Timolol Maleat Kullanımına Bağlı Semptomatik Bradikardi ve Senkop
by: Müge GÜLEN, et al.
Published: (2014-07-01)

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
by: Radcliffe NM
Published: (2014-12-01)

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate
by: Vinod Singh, et al.
Published: (2011-01-01)

Comment on "Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate"
by: Cynthia Arunachalam
Published: (2013-01-01)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
by: Inoue K, et al.
Published: (2015-04-01)

The reduction of intraocular pressure after instillation of travoprost compared with timolol in chronic primary angle-closure glaucoma
by: Edi S. Affandi, et al.
Published: (2006-11-01)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
by: Lerner SF, et al.
Published: (2019-12-01)

Design and evaluation of guargum - based timolol maleate ocular insert For the treatment of glaucoma
by: Sunil Thakral
Published: (2015-12-01)

Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
by: Rakić Danijela, et al.
Published: (2006-01-01)

Effects of timolol maleate eye drops on experimentally dilated cardiomyopathy and healthy rabbits
by: Mitsuhiro Isaka, et al.
Published: (2021-08-01)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
by: Hai Wei Wu, et al.
Published: (2017-06-01)

Simultaneous spectrofluorometric analysis of tablets containing hydrochlorothiazide combined with timolol maleate or amiloride hydrochloride
by: Wedian Fadel, et al.
Published: (2020-09-01)

Efficacy And Safety Of Travoprost Versus Timolol To Treat Early-Onset Ocular Hypertension Secondary To Vitrectomy: A Randomized Trial
by: Fang Y, et al.
Published: (2019-09-01)

Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma
by: Ryoko Igarashi, et al.
Published: (2014-01-01)

Clinical study of Fuming tablet combined with Timolol Maleate eye drops in the treatment of open angle glaucoma
by: Jin Li, et al.
Published: (2019-10-01)

Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
by: Costa VP, et al.
Published: (2012-05-01)

A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients
by: Alok Dixit, et al.
Published: (2020-04-01)

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
by: Fechtner RD, et al.
Published: (2011-07-01)

Formulation and release of timolol maleate from ocusert based on gelatin-N-(3-dimethylaminopropyl)-N-ethylcarbodiimide polymer
by: Mohammed Q. Kanaan, et al.
Published: (2021-03-01)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
by: Anton Hommer, et al.
Published: (2015-01-01)

Study of the therapeutic effect of oral propranolol combined with topical timolol maleate in the treatment of mixed maxillofacial hemangioma in infants
by: LI Jiapeng, et al.
Published: (2019-11-01)